精神分裂症心理社会干预的系统综述与质量评价
与常规治疗相比,早期干预服务在早期精神病全程症状上优于对照,认知行为疗法在精神分裂症全程症状上优于对照;其他干预对特定结局可能有益。
要点
- 早期精神病中,早期干预服务在治疗结束时和随访时对总体症状均优于常规治疗(SMD=-0.32/-0.21)。
- 精神分裂症中,认知行为疗法在治疗结束时和随访时对总体症状均优于常规治疗(SMD=-0.38/-0.19)。
- 与积极对照相比,早期精神病中混合家庭干预在随访时对总体症状更优(SMD=-0.61)。
核心结论
- 精神卫生服务应考虑优先提供早期精神病中的早期干预服务和任何家庭干预,以及精神分裂症中的认知行为疗法、认知矫正治疗、任何家庭干预和个体安置与支持,但其他干预可能对特定结局有帮助。
研究设计与样本
- 比较心理社会干预与常规治疗、积极干预或混合对照,主要结局为总体症状,次要结局包括阳性/阴性/抑郁症状、认知、功能、复发、住院、生活质量和治疗中断。
- 使用AMSTAR-PLUS工具将质量评为高、中、低。
主要发现
- 与常规治疗相比,早期精神病中早期干预服务在治疗结束时和随访时对总体症状均优于对照(SMD=-0.32/-0.21),认知行为疗法在精神分裂症治疗结束时和随访时对总体症状均优于对照(SMD=-0.38/-0.19)。
- 与常规治疗相比,早期精神病中早期干预服务在治疗结束时除认知外所有次要结局均更优,随访时对阳性症状、阴性症状和生活质量更优;特定家庭干预在治疗结束时预防复发。
- 与常规治疗相比,精神分裂症中认知行为疗法在治疗结束时对阳性症状、阴性症状、复发、功能和生活质量更优;心理教育/任何家庭干预对复发更优;认知矫正治疗对认知/功能更优;幻觉聚焦整合治疗对阳性症状更优。
- 与积极对照相比,早期精神病中混合家庭干预在随访时对总体症状更优(SMD=-0.61),并在功能/复发等次要结局更优;精神分裂症中正念和社会技能训练在治疗结束时对总体症状更优,认知行为疗法在随访时对总体症状更优。
- 与混合对照相比,精神分裂症中认知矫正治疗/心理教育在治疗结束时对总体症状更优(d=-0.14/SMD=-0.33),认知矫正治疗在治疗结束时对抑郁症状/社会功能更优,在治疗结束和随访时对阴性症状/认知/整体功能更优。
关键数值与推荐
- 与常规治疗相比,早期精神病中早期干预服务对总体症状的SMD在治疗结束时为-0.32,随访时为-0.21。
- 与常规治疗相比,精神分裂症中认知行为疗法对总体症状的SMD在治疗结束时为-0.38,随访时为-0.19。
- 与积极对照相比,早期精神病中混合家庭干预在随访时对总体症状的SMD为-0.61。
- 与混合对照相比,精神分裂症中认知矫正治疗/心理教育在治疗结束时对总体症状的效应量分别为d=-0.14和SMD=-0.33。
临床怎么用
- 精神卫生服务应考虑优先提供早期精神病中的早期干预服务和任何家庭干预。
- 精神卫生服务应考虑优先提供精神分裂症中的认知行为疗法、认知矫正治疗、任何家庭干预和个体安置与支持。
- 其他干预可能对特定结局有帮助。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psychosocial interventions are recommended in schizophrenia and first-episode psychosis/early psychosis (EP). Nevertheless, literature is heterogeneous and often contradictory. We conducted an umbrella review of (network) meta-analyses of randomized controlled trials (RCTs) comparing psychosocial interventions vs treatment as usual (TAU)/active interventions(ACTIVE)/MIXED controls. Primary outcome was total symptoms (TS); secondary outcomes were positive/negative/depressive symptoms (PS/NS/DS), cognition, functioning, relapse, hospitalization, quality of life (QoL), treatment discontinuation. Standardized mean difference (SMD)/odds ratio (OR)/risk ratio (RR) vs TAU/ACTIVE/MIXED were summarized at end-of-treatment (EoT)/follow-up (FU). Quality was rated as high/medium/low (AMSTAR-PLUS). Eighty-three meta-analyses were included (RCTs = 1246; n = 84,925). Against TAU, regarding TS, Early Intervention Services (EIS) were superior EoT/FU in EP (SMD = -0.32/-0.21), cognitive behavioral therapy (CBT) in schizophrenia EoT/FU (SMD = -0.38/-0.19). Regarding secondary outcomes, in EP, EIS were superior for all outcomes EoT except cognition, and at FU for PS/NS/QoL, specific family interventions (FI-s) prevented relapse EoT; in schizophrenia, superiority emerged EoT for CBT for PS/NS/relapse/functioning/QoL; psychoeducation (EDU)/any FI for relapse; cognitive remediation therapy (CRT) for cognition/functioning; and hallucination-focused integrative treatment for PS. Against ACTIVE, in EP, mixed family interventions (FI-m) were superior at FU regarding TS (SMD = -0.61) and for functioning/relapse among secondary outcomes. In schizophrenia, regarding TS, mindfulness and social skills training (SST) were superior EoT, CBT at FU; regarding secondary outcomes superiority emerged at EoT for computerized cognitive drill-and-practice training for PS/DS, CRT for cognition/functioning, EDU for relapse, individual placement and support (IPS) for employment; and at FU CBT for PS/NS. Against MIXED, in schizophrenia, CRT/EDU were superior for TS EoT (d = -0.14/SMD = -0.33), CRT regarding secondary outcomes EoT for DS/social functioning, both EoT/FU for NS/cognition/global functioning; compensatory cognitive interventions for PS/functioning EoT/FU and NS EoT; CBT for PS at FU, and EDU/SST for relapse EoT. In conclusion, mental health services should consider prioritizing EIS/any FI in EP and CBT/CRT/any FI/IPS for schizophrenia, but other interventions may be helpful for specific outcomes.
引用
- Solmi M, Croatto G, Piva G, et al. Efficacy and acceptability of psychosocial interventions in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence. Mol Psychiatry. 2022. PMID: 35999275. doi:10.1038/s41380-022-01727-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。